Full text
PDF



Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Berliner R. W., Earle D. P., Taggart J. V., Zubrod C. G., Welch W. J., Conan N. J., Bauman E., Scudder S. T., Shannon J. A. STUDIES ON THE CHEMOTHERAPY OF THE HUMAN MALARIAS. VI. THE PHYSIOLOGICAL DISPOSITION, ANTIMALARIAL ACTIVITY, AND TOXICITY OF SEVERAL DERIVATIVES OF 4-AMINOQUINOLINE. J Clin Invest. 1948 May;27(3 Pt 2):98–107. doi: 10.1172/JCI101980. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Desjardins R. E., Canfield C. J., Haynes J. D., Chulay J. D. Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique. Antimicrob Agents Chemother. 1979 Dec;16(6):710–718. doi: 10.1128/aac.16.6.710. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Douer D., Schwartz E., Shaked N., Ramot B. Amodiaquine-induced agranulocytosis: drug inhibition of myeloid colonies in the presence of patient's serum. Isr J Med Sci. 1985 Apr;21(4):331–334. [PubMed] [Google Scholar]
- Ette E. I., Essien E. E., Brown-Awala E. E. Pharmacokinetics of chloroquine: saliva and plasma levels relationship. Eur J Drug Metab Pharmacokinet. 1986 Oct-Dec;11(4):275–281. doi: 10.1007/BF03189112. [DOI] [PubMed] [Google Scholar]
- Geary T. G., Divo A. A., Jensen J. B. An in vitro assay system for the identification of potential antimalarial drugs. J Parasitol. 1983 Jun;69(3):577–583. [PubMed] [Google Scholar]
- Geary T. G., Jensen J. B. Lack of cross-resistance to 4-aminoquinolines in chloroquine-resistant Plasmodium falciparum in vitro. J Parasitol. 1983 Feb;69(1):97–105. [PubMed] [Google Scholar]
- Gluzman I. Y., Schlesinger P. H., Krogstad D. J. Inoculum effect with chloroquine and Plasmodium falciparum. Antimicrob Agents Chemother. 1987 Jan;31(1):32–36. doi: 10.1128/aac.31.1.32. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gustafsson L. L., Walker O., Alván G., Beermann B., Estevez F., Gleisner L., Lindström B., Sjöqvist F. Disposition of chloroquine in man after single intravenous and oral doses. Br J Clin Pharmacol. 1983 Apr;15(4):471–479. doi: 10.1111/j.1365-2125.1983.tb01532.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Henderson A., Simon J. W., Melia W. Failure of malaria chemoprophylaxis with a proguanil-chloroquine combination in Papua New Guinea. Trans R Soc Trop Med Hyg. 1986;80(5):838–840. doi: 10.1016/0035-9203(86)90398-6. [DOI] [PubMed] [Google Scholar]
- Jaeger A., Sauder P., Kopferschmitt J., Flesch F. Clinical features and management of poisoning due to antimalarial drugs. Med Toxicol Adverse Drug Exp. 1987 Jul-Aug;2(4):242–273. doi: 10.1007/BF03259868. [DOI] [PubMed] [Google Scholar]
- Kramer S. L., Campbell C. C., Moncrieff R. E. Fulminant Plasmodium falciparum infection treated with exchange blood transfusion. JAMA. 1983 Jan 14;249(2):244–245. doi: 10.1001/jama.1983.03330260062034. [DOI] [PubMed] [Google Scholar]
- Krogstad D. J., Herwaldt B. L., Schlesinger P. H. Antimalarial agents: specific treatment regimens. Antimicrob Agents Chemother. 1988 Jul;32(7):957–961. doi: 10.1128/aac.32.7.957. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Krogstad D. J., Schlesinger P. H. A perspective on antimalarial action: effects of weak bases on Plasmodium falciparum. Biochem Pharmacol. 1986 Feb 15;35(4):547–552. doi: 10.1016/0006-2952(86)90345-x. [DOI] [PubMed] [Google Scholar]
- Krogstad D. J., Schlesinger P. H., Herwaldt B. L. Antimalarial agents: mechanism of chloroquine resistance. Antimicrob Agents Chemother. 1988 Jun;32(6):799–801. doi: 10.1128/aac.32.6.799. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Larrey D., Castot A., Pëssayre D., Merigot P., Machayekhy J. P., Feldmann G., Lenoir A., Rueff B., Benhamou J. P. Amodiaquine-induced hepatitis. A report of seven cases. Ann Intern Med. 1986 Jun;104(6):801–803. doi: 10.7326/0003-4819-104-6-801. [DOI] [PubMed] [Google Scholar]
- Miller K. D., Lobel H. O., Pappaioanou M., Patchen L. C., Churchill F. C. Failures of combined chloroquine and Fansidar prophylaxis in American travelers to East Africa. J Infect Dis. 1986 Oct;154(4):689–691. doi: 10.1093/infdis/154.4.689. [DOI] [PubMed] [Google Scholar]
- Miller K. D., Lobel H. O., Satriale R. F., Kuritsky J. N., Stern R., Campbell C. C. Severe cutaneous reactions among American travelers using pyrimethamine-sulfadoxine (Fansidar) for malaria prophylaxis. Am J Trop Med Hyg. 1986 May;35(3):451–458. doi: 10.4269/ajtmh.1986.35.451. [DOI] [PubMed] [Google Scholar]
- Neftel K. A., Woodtly W., Schmid M., Frick P. G., Fehr J. Amodiaquine induced agranulocytosis and liver damage. Br Med J (Clin Res Ed) 1986 Mar 15;292(6522):721–723. doi: 10.1136/bmj.292.6522.721. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ohkuma S., Poole B. Fluorescence probe measurement of the intralysosomal pH in living cells and the perturbation of pH by various agents. Proc Natl Acad Sci U S A. 1978 Jul;75(7):3327–3331. doi: 10.1073/pnas.75.7.3327. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pang L. W., Limsomwong N., Boudreau E. F., Singharaj P. Doxycycline prophylaxis for falciparum malaria. Lancet. 1987 May 23;1(8543):1161–1164. doi: 10.1016/s0140-6736(87)92141-6. [DOI] [PubMed] [Google Scholar]
- Peto T. E., Gilks C. F. Strategies for the prevention of malaria in travellers: comparison of drug regimens by means of risk-benefit analysis. Lancet. 1986 May 31;1(8492):1256–1261. doi: 10.1016/s0140-6736(86)91395-4. [DOI] [PubMed] [Google Scholar]
- Phillips R. E., Warrell D. A., White N. J., Looareesuwan S., Karbwang J. Intravenous quinidine for the treatment of severe falciparum malaria. Clinical and pharmacokinetic studies. N Engl J Med. 1985 May 16;312(20):1273–1278. doi: 10.1056/NEJM198505163122001. [DOI] [PubMed] [Google Scholar]
- Rhodes E. G., Ball J., Franklin I. M. Amodiaquine induced agranulocytosis: inhibition of colony growth in bone marrow by antimalarial agents. Br Med J (Clin Res Ed) 1986 Mar 15;292(6522):717–718. doi: 10.1136/bmj.292.6522.717. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Schlesinger P. H., Krogstad D. J., Herwaldt B. L. Antimalarial agents: mechanisms of action. Antimicrob Agents Chemother. 1988 Jun;32(6):793–798. doi: 10.1128/aac.32.6.793. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Spencer H. C. Drug-resistant malaria--changing patterns mean difficult decisions. Trans R Soc Trop Med Hyg. 1985;79(6):748–758. doi: 10.1016/0035-9203(85)90108-7. [DOI] [PubMed] [Google Scholar]
- Spencer H. C., Kipingor T., Agure R., Koech D. K., Chulay J. D. Plasmodium falciparum in Kisumu, Kenya: differences in sensitivity to amodiaquine and chloroquine in vitro. J Infect Dis. 1983 Oct;148(4):732–736. doi: 10.1093/infdis/148.4.732. [DOI] [PubMed] [Google Scholar]
- Warhurst D. C. Antimalarial drugs. An update. Drugs. 1987 Jan;33(1):50–65. doi: 10.2165/00003495-198733010-00003. [DOI] [PubMed] [Google Scholar]
- Watkins W. M., Sixsmith D. G., Spencer H. C., Boriga D. A., Kariuki D. M., Kipingor T., Koech D. K. Effectiveness of amodiaquine as treatment for chloroquine-resistant Plasmodium falciparum infections in Kenya. Lancet. 1984 Feb 18;1(8373):357–359. doi: 10.1016/s0140-6736(84)90410-0. [DOI] [PubMed] [Google Scholar]
- White N. J., Watt G., Bergqvist Y., Njelesani E. K. Parenteral chloroquine for treating falciparum malaria. J Infect Dis. 1987 Feb;155(2):192–201. doi: 10.1093/infdis/155.2.192. [DOI] [PubMed] [Google Scholar]
- Wolfe M. S., Cordero J. F. Safety of chloroquine in chemosuppression of malaria during pregnancy. Br Med J (Clin Res Ed) 1985 May 18;290(6480):1466–1467. doi: 10.1136/bmj.290.6480.1466. [DOI] [PMC free article] [PubMed] [Google Scholar]